STOCK TITAN

Universe Pharma: August Luck discloses 9.29% stake

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Universe Pharmaceuticals INC (UPC) received a Schedule 13G reporting that August Luck Global Limited and Xuefeng Li together beneficially own 465,258 Class A ordinary shares. This represents 9.29% of the Class A ordinary shares, based on 5,008,313 shares outstanding as of July 27, 2026.

The 465,258 shares are held by August Luck Global Limited, a British Virgin Islands company that is wholly owned and controlled by Xuefeng Li of the People’s Republic of China. Both reporting persons disclose shared voting and dispositive power over these shares, with no sole voting or dispositive power.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 465,258 Class A ordinary shares Beneficial ownership reported by August Luck Global Limited and Xuefeng Li
Percent of class 9.29% Ownership percentage of UPC Class A ordinary shares
Shares outstanding 5,008,313 Class A ordinary shares Shares outstanding as of July 27, 2026, used to calculate ownership percentage
Shared voting power 465,258 shares Number of UPC shares over which each reporting person has shared voting power
Sole voting power 0 shares UPC shares over which the reporting persons have sole voting power
Shared dispositive power 465,258 shares UPC shares over which each reporting person has shared dispositive power
beneficially owned financial
"Item 4. | Ownership (a) | Amount beneficially owned: August Luck Global Limited: 465,258.00"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power financial
"6 | Shared Voting Power 465,258.00 7 | Sole Dispositive Power 0.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"8 | Shared Dispositive Power 465,258.00 9 465,258.00"
Schedule 13G regulatory
""form_type": "SCHEDULE 13G""
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

What percentage of Universe Pharmaceuticals INC (UPC) does August Luck Global Limited beneficially own?

August Luck Global Limited beneficially owns 9.29% of Universe Pharmaceuticals INC’s Class A ordinary shares, representing 465,258 shares, based on 5,008,313 Class A ordinary shares outstanding as of July 27, 2026.

How many UPC Class A shares are reported as beneficially owned by Xuefeng Li?

Xuefeng Li is reported as beneficially owning 465,258 Class A ordinary shares of Universe Pharmaceuticals INC, the same block held by August Luck Global Limited, over which he has shared voting and dispositive power.

What is the relationship between August Luck Global Limited and Xuefeng Li in the UPC Schedule 13G?

The filing states that the 465,258 UPC Class A ordinary shares are held by August Luck Global Limited, which is wholly owned and controlled by Xuefeng Li. Both report shared voting and dispositive power over the same shares.

On what share count is the 9.29% ownership of UPC based?

The 9.29% ownership figure is calculated based on 5,008,313 Class A ordinary shares of Universe Pharmaceuticals INC outstanding as of July 27, 2026.

Does the reporting person have sole or shared voting power over UPC shares?

The Schedule 13G reports 0 UPC shares with sole voting or dispositive power and 465,258 shares with shared voting and shared dispositive power for each of August Luck Global Limited and Xuefeng Li.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





G9442G138

(CUSIP Number)
07/27/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The amount in rows 6, 8 and 9 represents 465,258 Class A ordinary shares held by August Luck Global Limited, a company with limited liability formed in the British Virgin Islands. August Luck Global Limited is wholly owned and controlled by Xuefeng Li, an individual. Percentage of class is calculated based on 5,008,313 Class A ordinary shares outstanding as of July 27, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The amount in rows 6, 8 and 9 represents 465,258 Class A ordinary shares held by August Luck Global Limited, a company with limited liability formed in the British Virgin Islands. August Luck Global Limited is wholly owned and controlled by Xuefeng Li, an individual. Percentage of class is calculated based on 5,008,313 Class A ordinary shares outstanding as of July 27, 2026.


SCHEDULE 13G



August Luck Global Limited
Signature:/s/ Xuefeng Li
Name/Title:Xuefeng Li/Director
Date:09/01/2026
Xuefeng Li
Signature:/s/ Xuefeng Li
Name/Title:Xuefeng Li
Date:09/01/2026
Exhibit Information

Exhibit 99.1 - Joint Filing Agreement